Author: Olivia Zelling
-
From Policy to Practice: The Breakdown of Chicago’s Hospital Price Transparency
•
Imagine: After her doctor recommended a hip replacement, a 67-year-old Chicago grandmother sat down at her computer hoping to compare prices before scheduling surgery. Instead, she spent nearly an hour navigating hospital websites, clicking through estimator tools that asked for billing codes she did not recognize and insurance details she…
-
In Defense of Detemir: How US Drug Policy Let an Essential Insulin Disappear
•
In December 2024, Novo Nordisk discontinued insulin detemir (levemir) in the U.S. They cited manufacturing constraints, alternative insulins, and reduced formulary coverage. This decision removed one of only three basal insulin options. No generic could replace it since the FDA does not allow compounding of insulins, and expedited pathways still…